PRNewsWire
08 Jul 2026, 00:54 UTC · 11w ago
Verdict
Headline takes no side. We score MDLN −1.00 across four claims — strongly bearish.
−1.00strongly bearish
More negative than 95% of ticker scores this week
What the story claims
4 claims · scored −1 bearish … +1 bullish
The FDA issued a warning letter stating Medline's drug products are adulterated due to Current Good Manufacturing Practice (CGMP) violations.
More negative than 99% of claims this week
Medline shut down certain manufacturing facilities in October 2025 due to quality problems, a fact disclosed to investors only in June 2026.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 2 movers · tap to explore
More negative than 98% of claims this week
Hagens Berman Sobol Shapiro has launched an investigation into whether Medline misled investors regarding manufacturing quality and FDA compliance.
More negative than 91% of claims this week
Revelations regarding Medline's quality failures resulted in an approximate $2.2 billion loss in market capitalization.
More negative than 78% of claims this week
Which stocks this story touches
More negative than 95% of ticker scores this week
The company is under investigation for misleading investors and facing FDA warning letters regarding adulterated products and manufacturing violations.
More negative than 75% of ticker scores this week
The company is facing a securities class action lawsuit related to surprise disclosures made to investors.
More negative than 75% of ticker scores this week
The company is mentioned in the context of an expanded class period for a securities class action lawsuit.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
PRNewsWire
2h ago
−19.4%
Price agrees with the score
$34.66 vs $43.01 close before publication (Jul 7) · not market-adjusted
MDLN chart →
